Osteoporosis Update From the 2010 Santa Fe Bone Symposium

E. Michael Lewiecki, John P. Bilezikian, Sundeep Khosla, Robert Marcus, Michael R. McClung, Paul D. Miller, Nelson B. Watts, Michael Maricic

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The 11th Santa Fe Bone Symposium was held in Santa Fe, NM, USA, on August 6-7, 2010. This annual event addresses clinically relevant advances in the fields of osteoporosis and metabolic bone disease. The venue includes plenary presentations by internationally recognized experts, oral presentations of abstracts, and interactive panel discussions of challenging cases and controversial issues. Attendees are active participants throughout the symposium program. Topics for the 2010 symposium included potential applications of novel technologies for the assessment of skeletal health for research and clinical practice; new and emerging treatments for osteoporosis; appropriate use of pharmacological agents to prevent osteoporosis; controversies with bisphosphonate therapy; practical applications of the World Health Organization fracture risk assessment tool (FRAX; World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK); insights into the use of osteoanabolic agents to enhance fracture healing; and challenges in laboratory testing in the assessment of factors contributing to skeletal fragility. Concurrent sessions focused on critical thinking for technologists in the acquisition and analysis of data with dual-energy X-ray absorptiometry. The key messages from each presentation, including the best available medical evidence and potential current and future clinical applications, are provided here.

Original languageEnglish (US)
Pages (from-to)1-21
Number of pages21
JournalJournal of Clinical Densitometry
Volume14
Issue number1
DOIs
StatePublished - Jan 2011

Fingerprint

Osteoporosis
Metabolic Bone Diseases
Bone and Bones
Biomedical Technology Assessment
Fracture Healing
Photon Absorptiometry
Diphosphonates
Pharmacology
Research
Therapeutics
Thinking

Keywords

  • Bisphosphonate
  • Denosumab
  • Emerging
  • Fracture
  • Osteoporosis

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Orthopedics and Sports Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Lewiecki, E. M., Bilezikian, J. P., Khosla, S., Marcus, R., McClung, M. R., Miller, P. D., ... Maricic, M. (2011). Osteoporosis Update From the 2010 Santa Fe Bone Symposium. Journal of Clinical Densitometry, 14(1), 1-21. https://doi.org/10.1016/j.jocd.2010.12.001

Osteoporosis Update From the 2010 Santa Fe Bone Symposium. / Lewiecki, E. Michael; Bilezikian, John P.; Khosla, Sundeep; Marcus, Robert; McClung, Michael R.; Miller, Paul D.; Watts, Nelson B.; Maricic, Michael.

In: Journal of Clinical Densitometry, Vol. 14, No. 1, 01.2011, p. 1-21.

Research output: Contribution to journalArticle

Lewiecki, EM, Bilezikian, JP, Khosla, S, Marcus, R, McClung, MR, Miller, PD, Watts, NB & Maricic, M 2011, 'Osteoporosis Update From the 2010 Santa Fe Bone Symposium', Journal of Clinical Densitometry, vol. 14, no. 1, pp. 1-21. https://doi.org/10.1016/j.jocd.2010.12.001
Lewiecki, E. Michael ; Bilezikian, John P. ; Khosla, Sundeep ; Marcus, Robert ; McClung, Michael R. ; Miller, Paul D. ; Watts, Nelson B. ; Maricic, Michael. / Osteoporosis Update From the 2010 Santa Fe Bone Symposium. In: Journal of Clinical Densitometry. 2011 ; Vol. 14, No. 1. pp. 1-21.
@article{8af6282a5bdc4df6a8eccc597e522bbd,
title = "Osteoporosis Update From the 2010 Santa Fe Bone Symposium",
abstract = "The 11th Santa Fe Bone Symposium was held in Santa Fe, NM, USA, on August 6-7, 2010. This annual event addresses clinically relevant advances in the fields of osteoporosis and metabolic bone disease. The venue includes plenary presentations by internationally recognized experts, oral presentations of abstracts, and interactive panel discussions of challenging cases and controversial issues. Attendees are active participants throughout the symposium program. Topics for the 2010 symposium included potential applications of novel technologies for the assessment of skeletal health for research and clinical practice; new and emerging treatments for osteoporosis; appropriate use of pharmacological agents to prevent osteoporosis; controversies with bisphosphonate therapy; practical applications of the World Health Organization fracture risk assessment tool (FRAX; World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK); insights into the use of osteoanabolic agents to enhance fracture healing; and challenges in laboratory testing in the assessment of factors contributing to skeletal fragility. Concurrent sessions focused on critical thinking for technologists in the acquisition and analysis of data with dual-energy X-ray absorptiometry. The key messages from each presentation, including the best available medical evidence and potential current and future clinical applications, are provided here.",
keywords = "Bisphosphonate, Denosumab, Emerging, Fracture, Osteoporosis",
author = "Lewiecki, {E. Michael} and Bilezikian, {John P.} and Sundeep Khosla and Robert Marcus and McClung, {Michael R.} and Miller, {Paul D.} and Watts, {Nelson B.} and Michael Maricic",
year = "2011",
month = "1",
doi = "10.1016/j.jocd.2010.12.001",
language = "English (US)",
volume = "14",
pages = "1--21",
journal = "Journal of Clinical Densitometry",
issn = "1094-6950",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Osteoporosis Update From the 2010 Santa Fe Bone Symposium

AU - Lewiecki, E. Michael

AU - Bilezikian, John P.

AU - Khosla, Sundeep

AU - Marcus, Robert

AU - McClung, Michael R.

AU - Miller, Paul D.

AU - Watts, Nelson B.

AU - Maricic, Michael

PY - 2011/1

Y1 - 2011/1

N2 - The 11th Santa Fe Bone Symposium was held in Santa Fe, NM, USA, on August 6-7, 2010. This annual event addresses clinically relevant advances in the fields of osteoporosis and metabolic bone disease. The venue includes plenary presentations by internationally recognized experts, oral presentations of abstracts, and interactive panel discussions of challenging cases and controversial issues. Attendees are active participants throughout the symposium program. Topics for the 2010 symposium included potential applications of novel technologies for the assessment of skeletal health for research and clinical practice; new and emerging treatments for osteoporosis; appropriate use of pharmacological agents to prevent osteoporosis; controversies with bisphosphonate therapy; practical applications of the World Health Organization fracture risk assessment tool (FRAX; World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK); insights into the use of osteoanabolic agents to enhance fracture healing; and challenges in laboratory testing in the assessment of factors contributing to skeletal fragility. Concurrent sessions focused on critical thinking for technologists in the acquisition and analysis of data with dual-energy X-ray absorptiometry. The key messages from each presentation, including the best available medical evidence and potential current and future clinical applications, are provided here.

AB - The 11th Santa Fe Bone Symposium was held in Santa Fe, NM, USA, on August 6-7, 2010. This annual event addresses clinically relevant advances in the fields of osteoporosis and metabolic bone disease. The venue includes plenary presentations by internationally recognized experts, oral presentations of abstracts, and interactive panel discussions of challenging cases and controversial issues. Attendees are active participants throughout the symposium program. Topics for the 2010 symposium included potential applications of novel technologies for the assessment of skeletal health for research and clinical practice; new and emerging treatments for osteoporosis; appropriate use of pharmacological agents to prevent osteoporosis; controversies with bisphosphonate therapy; practical applications of the World Health Organization fracture risk assessment tool (FRAX; World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK); insights into the use of osteoanabolic agents to enhance fracture healing; and challenges in laboratory testing in the assessment of factors contributing to skeletal fragility. Concurrent sessions focused on critical thinking for technologists in the acquisition and analysis of data with dual-energy X-ray absorptiometry. The key messages from each presentation, including the best available medical evidence and potential current and future clinical applications, are provided here.

KW - Bisphosphonate

KW - Denosumab

KW - Emerging

KW - Fracture

KW - Osteoporosis

UR - http://www.scopus.com/inward/record.url?scp=79551481740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551481740&partnerID=8YFLogxK

U2 - 10.1016/j.jocd.2010.12.001

DO - 10.1016/j.jocd.2010.12.001

M3 - Article

C2 - 21295739

AN - SCOPUS:79551481740

VL - 14

SP - 1

EP - 21

JO - Journal of Clinical Densitometry

JF - Journal of Clinical Densitometry

SN - 1094-6950

IS - 1

ER -